A Novel Potential Therapy for Spinal Muscular Atrophy

被引：1
|
作者：
Michio Hirano
机构：
来源：
Current Neurology and Neuroscience Reports | 2003年 / 3卷 / 1期
关键词：
Lean Body Mass; Thymoma; Spinal Muscular Atrophy; Albuterol; Maximum Voluntary Isometric Contraction;
D O I：
10.1007/s11910-003-0038-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：56 / 56
相关论文
共 50 条
  • [21] Spinal muscular atrophy. Diagnosis and therapy
    Borell, S.
    Pechmann, A.
    Kirschner, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2015, 163 (12) : 1293 - 1301
  • [22] A gene therapy approach to spinal muscular atrophy
    Baloglu, S
    Cucchiarini, M
    Francis, JW
    Terwilliger, EF
    MOLECULAR THERAPY, 2003, 7 (05) : S191 - S191
  • [23] miRNA in spinal muscular atrophy pathogenesis and therapy
    Magri, Francesca
    Vanoli, Fiammetta
    Corti, Stefania
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (02) : 755 - 767
  • [24] From pathogenesis to therapy in spinal muscular atrophy
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S1 - S1
  • [25] Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy
    Finkel, Richard S.
    Hughes, Samuel H.
    Parker, Julieann
    Civitello, Matthew
    Lavado, Alfonso
    Mefford, Heather C.
    Mueller, Lutz
    Kletzl, Heidemarie
    Prenatal SMA Risdiplam Study Grp
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [26] Novel therapeutic strategies for spinal muscular atrophy
    Khwaja, Omar
    Clarke, Ellen
    FUTURE NEUROLOGY, 2015, 10 (04) : 309 - 311
  • [27] Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy
    Abreu, Nicolas J.
    Waldrop, Megan A.
    PEDIATRIC PULMONOLOGY, 2021, 56 (04) : 710 - 720
  • [28] Spinal Muscular Atrophy: Development and Implementation of Potential Treatments
    Arnold, W. David
    Burghes, Arthur H. M.
    ANNALS OF NEUROLOGY, 2013, 74 (03) : 348 - 362
  • [29] GEMINs: potential therapeutic targets for spinal muscular atrophy?
    Borg, Rebecca
    Cauchi, Ruben J.
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [30] Gene therapy for spinal muscular atrophy: timing is key
    Servais, Laurent
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
12345